您的位置: 首页 > 农业专利 > 详情页

工程化嵌合抗原受體(CAR)T細胞的人應用
专利权人:
Board of Regents The University of Texas System
发明人:
COOPER, Laurence, J.N.,WANG-JOHANNING, Feng,TORIKAI, Horoki,HULS, Helen,HURTON, Lenka,KRISHNAMURTHY, Janani,OLIVARES, Simon,ZHANG, Ling
申请号:
HK16110667.3
公开号:
HK1222674A
申请日:
2016.09.08
申请国别(地区):
HK
年份:
2017
代理人:
摘要:
The present invention concerns methods and compositions for immunotherapy employing a modified T cell comprising a chimeric antigen receptor (CAR). In particular aspects, CAR-expressing T-cells are producing using electroporation in conjunction with a transposon-based integration system to produce a population of CAR-expressing cells that require minimal ex vivo expansion or that can be directly administered to patients for disease (e.g., cancer) treatment.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充